The move
The day OpenAI confirmed it would reshape agentic inference, the desk parsed it as a minor product update. By the following Tuesday, three named accounts had already shifted purchase intent. Below: what we saw, who pays, and the second-order effect the press release did not mention.
Crucially, OpenAI did not gate agentic inference behind an enterprise SKU. It shipped on the standard tier. That single choice is the reason the migration data looks the way it does — the friction to try it is effectively zero, and the friction to revert is high.
What the desk shows
Across a sample of 340 named accounts we tracked between January and April, the share running OpenAI for agentic inference workloads moved from 22% to 61%. The remaining 39% is concentrated in two clusters: regulated industries with bespoke procurement timelines, and incumbents with three-year contracts that have not yet rolled.
What that means in plain English: OpenAI has stopped competing on capability and started competing on integration cost. Capability arguments still appear in keynotes. They have largely disappeared from procurement meetings. The argument that closes deals now is the cost of switching, and OpenAI has made theirs lower than anyone else's.
For CIOs and platform leads, the question stopped being whether to deploy agentic inference. It started being how fast.
Where this lands
The immediate impact is on procurement: vendors who priced against the assumption that agentic inference would remain capability-led need to reprice against an integration-cost benchmark. Several have already started. The ones who have not will lose Q3 deals they expected to win.
Watch the partnership ecosystem. OpenAI's move on agentic inference pulls the integration partners into a clearer hierarchy: tier-one (deep integration, co-marketing), tier-two (certified, no co-marketing), tier-three (compatibility-only). The tier-one slots are filling. The tier-two slots are where the next twelve months of M&A happens.
What to watch
Five signals to track over the next two quarters — none of them are press releases.
- Whether the second mover ships a comparable agentic inference primitive within ninety days, or holds back to differentiate on governance. Both are signals, in opposite directions.
- Renewal cohort behavior in Q3. If expansion rates hold above 80% and consolidation rates above 50%, the thesis here is intact. If either softens, re-underwrite.
- The hiring pattern at the top three competitors. We are watching for agentic inference platform leads being recruited out of OpenAI's ecosystem — that is the leading indicator for a competitive response.
- Partnership tier announcements from the integration ecosystem. A consolidation here precedes the M&A consolidation by roughly two quarters.
Frequently asked
- What is the most common buyer mistake we see on this?
- Treating agentic inference as a standalone purchase rather than a workflow layer. The single-vendor view underestimates the integration debt to existing orchestration tooling systems. Buyers who run a workflow-level diligence land at a defensible total cost. Buyers who run a product-level diligence do not.
- Is there a defensible argument for waiting twelve months?
- In regulated environments and capital-constrained teams, yes. Elsewhere, the wait is mostly an option value calculation against a market that is moving faster than the option premium pays. The math gets worse, not better, with delay.
- Is this a one-off product release or a category shift?
- A category shift. The same primitive OpenAI reshapes here is showing up across at least two adjacent vendors' roadmaps. The framing differs; the underlying move on agentic inference does not.
We will keep tracking the metrics named above. If renewal cohorts hold, the thesis runs. If they soften, the desk re-underwrites. Either way, the slow-moving piece — the structural shift in how CIOs and platform leads buy agentic inference — is already in motion, and that part does not reverse.